Diffuse midline gliomas
Chimerix’s ONC201 Shows Promise Against H3K27M-Mutant Gliomas
Anika Sharma
Chimerix, a biopharmaceutical company committed to enhancing and extending the lives of patients grappling with severe diseases, has unveiled significant ...
